The Health Ministry's Department for the Treatment of Substance Abuse's Policy Regarding: Treating Opiate Addicts with Medication for an Extended Period of Time (using agonist or partial agonist drugs, e.g. methadone, buprenorphine)
Ministry of Health
State of Israel
Country Resources
Substance Abuse Policies
Israel
Policy document
Print
This translation feature uses a third-party service. Please be advised that the machine-translated content may not be accurate. Translation only applies to this page and is not available for downloaded files or external links.
Description
The Health Ministry's Department for the Treatment of Substance Abuse's Policy Regarding: Treating Opiate Addicts with Medication for an Extended Period of Time (using agonist or partial agonist drugs, e.g. methadone, buprenorphine)Table of Contents:
1 Key points in the policy for treating opiate addicts with medication for an extended period of time.
2 Introduction
3 The target population and treatment goals
4 Qualifying for treatment (intake committee and criteria)
5 Guidelines for medical treatment and psychosocial therapy
6 Treating patients with extenuating circumstances
7 Patient rights
8 Providing doses of methadone//buprenorphine for trips abroad.
9 Accepting tourist patients for limited durations of time
10 Obligation to report
11 Oversight
12 Appendix A: The staff
Content
WHO collates and provides external links to resources focusing on mental health, disability, general health, human rights and development but does not specifically endorse particular laws, policies, plans or other documents from countries or organisations. WHO also does not warrant that the information in this record is correct or refers to the most up-to-date version. Please read the site disclaimer for further details. If this record contains an error or is outdated, please notify us.
